Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 44 Neoplasm Metastasis 19 Liver Neoplasms 18 Colorectal Neoplasms 15 Cholangiocarcinoma 11 Pancreatic Neoplasms 9 Lung Neoplasms 9 Colonic Neoplasms 9 Breast Neoplasms 8 Carcinoma, Renal Cell 7 Carcinoma, Non-Small-Cell Lung 7 Barrett Esophagus 7 Thyroid Nodule 6 Recurrence 6 Rectal Neoplasms 6 Thyroid Neoplasms 5 Pain 4 Neoplasms 4 Kidney Neoplasms 4 Esophageal Neoplasms 4 Thyroid Cancer, Papillary 3 Prostatic Neoplasms 3 Leiomyoma 3 Biliary Tract Neoplasms 3 Bile Duct Neoplasms 3 Agnosia 3 Thyroid Diseases 2 Hyperaldosteronism 2 Hepatitis B 2 Gallbladder Neoplasms 2

Interventions

Everolimus 9 Temozolomide 7 Sunitinib 7 Specimen Handling 4 Octreotide 4 Magnetic Resonance Spectroscopy 4 Fluorouracil 4 Capecitabine 4 lutetium Lu 177 dotatate 3 Leucovorin 3 sargramostim 2 montanide ISA 51 2 incomplete Freund's adjuvant 2 cabozantinib 2 Thalidomide 2 Streptozocin 2 Sorafenib 2 Oxaliplatin 2 Irinotecan 2 Injections 2 Endoscopic Ultrasound-Guided Fine Needle Aspiration 2 Doxorubicin 2 Cytoreduction Surgical Procedures 2 Colony-Stimulating Factors 2 Bevacizumab 2 surufatinib 1 sapanisertib 1 recombinant interferon alpha 2b-like protein 1 pentetreotide 1 pasireotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenoma, Islet Cell × Radiofrequency Ablation × Clear all

NCT04520932 2025-05-25

RFANET

Institut Paoli-Calmettes

Phase NA Recruiting

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡